National Heart, Lung, and Blood Institute; Notice of Meeting, 65786 [2022-23689]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
65786
Federal Register / Vol. 87, No. 210 / Tuesday, November 1, 2022 / Notices
Federal agencies relevant to the
diagnosis, prevention, and treatment of
pain and diseases and disorders
associated with pain; (b) identify critical
gaps in basic and clinical research on
the symptoms and causes of pain; (c)
make recommendations to ensure that
the activities of the National Institutes
of Health and other Federal agencies are
free of unnecessary duplication of effort;
(d) make recommendations on how best
to disseminate information on pain care;
and (e) make recommendations on how
to expand partnerships between public
entities and private entities to expand
collaborative, cross-cutting research.
Membership on the committee will
include six (6) non-Federal members
from among scientists, physicians, and
other health professionals and six (6)
non-Federal members of the general
public who are representatives of
leading research, advocacy, and service
organizations for individuals with painrelated conditions. Members will serve
overlapping three-year terms. It is
anticipated that the committee will meet
at least once a year.
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of diverse ethnic and racial groups and
people with disabilities are represented
on HHS Federal advisory committees,
and the Department, therefore,
encourages nominations of qualified
candidates from these groups. The
Department also encourages geographic
diversity in the composition of the
Committee. Appointment to this
Committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
The Department is soliciting
nominations for one (1) non-Federal
member from among scientists,
physicians, and other health
professionals and for two (2) nonFederal members of the general public
who represent a leading research,
advocacy, or service organization for
people with pain-related conditions.
These candidates will be considered to
fill positions opened through
completion of current member terms.
Nominations are due by 5:00 p.m. EST
on November 30, 2022, using the
following webform: https://
VerDate Sep<11>2014
17:11 Oct 31, 2022
Jkt 259001
www.surveymonkey.com/r/iprccmember-nomination-form.
Walter J. Koroshetz,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2022–23700 Filed 10–31–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Sleep Disorders Research
Advisory Board.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Sleep Disorders
Research Advisory Board.
Date: December 1, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: The purpose of this meeting is to
update the Advisory Board and public
stakeholders on the research agenda across
NIH for the upcoming fiscal year, and the
activities of professional societies.
Place: Virtual-Teleconference and
ZoomGov.
Telephone Access: 1–669–254–5252
(Meeting ID:160 764 0327 Passcode: 416595).
Virtual Access: https://nih.zoomgov.com/j/
1607640327?pwd=bFlKdkNKcUNhblp6Vlcz
SnVmOGtyZz09 (Meeting ID:160 764 0327
Passcode: 416595).
Contact Person: Marishka Brown Ph.D.,
SDRAB Executive Secretary, Director,
National Center on Sleep Disorders Research,
National Heart, Lung, and Blood Institute,
National Institutes of Health, 6705 Rockledge
Dr., RKL1/407–B, Bethesda, MD 20814–7952,
301.435.0199, ncsdr@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: October 26, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–23689 Filed 10–31–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Institutional Training Mechanism Study
Section.
Date: December 2, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, RKI,
6705 Rockledge Drive, Bethesda, MD 20850
(Virtual Meeting).
Contact Person: Michael Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6705 Rockledge Drive, Room
208–Z, Bethesda, MD 20892, 301–827–7975,
reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood 1Diseases
E:\FR\FM\01NON1.SGM
01NON1
]]>Agencies
[Federal Register Volume 87, Number 210 (Tuesday, November 1, 2022)]
[Notices]
[Page 65786]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23689]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sleep Disorders
Research Advisory Board.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sleep Disorders Research Advisory Board.
Date: December 1, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: The purpose of this meeting is to update the Advisory
Board and public stakeholders on the research agenda across NIH for
the upcoming fiscal year, and the activities of professional
societies.
Place: Virtual-Teleconference and ZoomGov.
Telephone Access: 1-669-254-5252 (Meeting ID:160 764 0327
Passcode: 416595).
Virtual Access: https://nih.zoomgov.com/j/1607640327?pwd=bFlKdkNKcUNhblp6VlczSnVmOGtyZz09 (Meeting ID:160 764
0327 Passcode: 416595).
Contact Person: Marishka Brown Ph.D., SDRAB Executive Secretary,
Director, National Center on Sleep Disorders Research, National
Heart, Lung, and Blood Institute, National Institutes of Health,
6705 Rockledge Dr., RKL1/407-B, Bethesda, MD 20814-7952,
301.435.0199, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: October 26, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-23689 Filed 10-31-22; 8:45 am]
BILLING CODE 4140-01-P
